← Explore

Ultrasound does not activate but can inhibit in vivo mammalian nerves across a wide range of parameters

Hongsun Guo, Sarah J. Offutt, Mark Hamilton II, Yohan Kim, Cory D. Gloeckner, Daniel P. Zachs, Jamu K. Alford, Hubert H. Lim

Scientific Reports 2022, 12 · 10.1038/s41598-022-05226-7

rodenthealthyinvasive electrophysiology

Abstract

Ultrasound (US) has been shown to stimulate brain circuits, however, the ability to excite peripheral nerves with US remains controversial. To the best of our knowledge, there is still no in vivo neural recording study that has applied US stimulation to a nerve isolated from surrounding tissue to confirm direct activation effects. Here, we show that US cannot excite an isolated mammalian sciatic nerve in an in vivo preparation, even at high pressures (relative to levels recommended in the FDA guidance for diagnostic ultrasound) and for a wide range of parameters, including different pulse patterns and center frequencies. US can, however, reliably inhibit nerve activity whereby greater suppression is correlated with increases in nerve temperature. By prohibiting the nerve temperature from increasing during US application, we did not observe suppressive effects. Overall, these findings demonstrate that US can reliably inhibit nerve activity through a thermal mechanism that has potential for various health disorders, though future studies are needed to evaluate the long-term safety of therapeutic ultrasound applications.

Abstract via europepmc.

Speciesguinea pig
Subjects41 animals
Sessions per subjectnot reported
Randomisednot reported
Blindingnot reported
Sham / controlnone
Auditory controlnot reported
Readout timingboth
Anaesthesiaanaesthetised
Readoutsinvasive electrophysiologyCompound action potentials (CAPs) recorded directly from the sciatic nerve; multi-unit activity recorded from somatosensory cortex (SSC) with a 32-site electrode array; nerve temperature via hypodermic thermocouple
Direction of effectinhibitoryUS could not directly excite the sciatic nerve at any of the wide range of parameters tested (including pressures/intensities well above FDA diagnostic-ultrasound guidance levels), but reliably suppressed electrically-evoked sciatic-nerve compound action potentials in a hammocked (isolated) nerve preparation, with greater suppression accompanying higher ISPTA, pressure, pulse duration and larger increases in nerve temperature, consistent with a thermally-dominant mechanism; cooling the nerve during US prevented suppression.
Adverse eventsnot reportedNo histological assessment of nerve damage was performed; nerve activity fully recovered to baseline within five minutes after cessation of US stimulation for all parameters tested (0.046 to 1.728 W/cm2 ISPTA).

Exposures

Exposure 1: 220 kHz US to sciatic nerve (hammocked/exposed/noninvasive preparations)

Target: sciatic nerve — “sciatic nerve
Device: Sonic Concepts · Sonic Concepts · 071–02-SN01 (custom)

Pulse timing
Waveformcontinuous, pulsed
Fundamental frequency (kHz)220✓✓
Pulse duration (ms)0.01, 500swept✓✓
Pulse repetition frequency (Hz)10, 5,000swept✓✓
Duty cycle (%)0.99, 50, 99.01swept✓✓
Sonication duration (s)0.02✓✓
Pressure and intensity, by domain
Free-field pressure (kPa)50, 2,000swept✓✓
Free-field Isppa (W/cm²)not reported
Free-field Ispta (W/cm²)not reported
In-situ estimatenot reported
In-situ pressure (kPa)not reported
In-situ Isppa (W/cm²)not reported
In-situ Ispta (W/cm²)not reported
Protocol, in the paper’s words

US was tested in both single-pulse mode (one burst per trial, PD from 0.01-500 ms, TD 0.5/1/3 s, duty cycle 0.99-99.01%) and multiple-pulse mode (PRF 10 Hz-5 kHz at 50% duty cycle, 1 s TD) to attempt nerve excitation (non-invasive, exposed, and hammocked/isolated-nerve preparations). In separate nerve-modulation (EU-paired) experiments, single-pulse US (PD 0.05/0.1/1/10/100/500 ms) with maximum pressures of 1.62, 1.17 and 2.7 MPa and minimum pressures of 0.03, 0.05 and 0.16 MPa (for the 0.22, 0.52 and 1 MHz transducers respectively) was paired with electrical stimulation of the foot to assess suppression of sciatic-nerve compound action potentials.

Exposure 2: 520 kHz US to sciatic nerve (hammocked/exposed/noninvasive preparations)

Target: sciatic nerve — “sciatic nerve
Device: Ultran · The Ultran Group · GS500-D30

Pulse timing
Waveformcontinuous, pulsed
Fundamental frequency (kHz)520✓✓
Pulse duration (ms)0.01, 500swept✓✓
Pulse repetition frequency (Hz)10, 5,000swept✓✓
Duty cycle (%)0.99, 50, 99.01swept✓✓
Sonication duration (s)0.075✓✓
Pressure and intensity, by domain
Free-field pressure (kPa)100, 1,300swept✓✓
Free-field Isppa (W/cm²)not reported
Free-field Ispta (W/cm²)not reported
In-situ estimatenot reported
In-situ pressure (kPa)not reported
In-situ Isppa (W/cm²)not reported
In-situ Ispta (W/cm²)not reported
Protocol, in the paper’s words

US was tested in both single-pulse mode (one burst per trial, PD from 0.01-500 ms, TD 0.5/1/3 s, duty cycle 0.99-99.01%) and multiple-pulse mode (PRF 10 Hz-5 kHz at 50% duty cycle, 1 s TD) to attempt nerve excitation (non-invasive, exposed, and hammocked/isolated-nerve preparations). In separate nerve-modulation (EU-paired) experiments, single-pulse US (PD 0.05/0.1/1/10/100/500 ms) with maximum pressures of 1.62, 1.17 and 2.7 MPa and minimum pressures of 0.03, 0.05 and 0.16 MPa (for the 0.22, 0.52 and 1 MHz transducers respectively) was paired with electrical stimulation of the foot to assess suppression of sciatic-nerve compound action potentials.

Exposure 3: 1000 kHz US to sciatic nerve (hammocked/exposed/noninvasive preparations)

Target: sciatic nerve — “sciatic nerve
Device: Sonic Concepts · Sonic Concepts · H-218

Pulse timing
Waveformcontinuous, pulsed
Fundamental frequency (kHz)1,000✓✓
Pulse duration (ms)0.01, 500swept✓✓
Pulse repetition frequency (Hz)10, 5,000swept✓✓
Duty cycle (%)0.99, 50, 99.01swept✓✓
Sonication duration (s)0.075✓✓
Pressure and intensity, by domain
Free-field pressure (kPa)100, 5,000swept✓✓
Free-field Isppa (W/cm²)833✓✓
Free-field Ispta (W/cm²)62.48✓✓
In-situ estimatenot reported
In-situ pressure (kPa)not reported
In-situ Isppa (W/cm²)not reported
In-situ Ispta (W/cm²)not reported
Protocol, in the paper’s words

US was tested in both single-pulse mode (one burst per trial, PD from 0.01-500 ms, TD 0.5/1/3 s, duty cycle 0.99-99.01%) and multiple-pulse mode (PRF 10 Hz-5 kHz at 50% duty cycle, 1 s TD) to attempt nerve excitation (non-invasive, exposed, and hammocked/isolated-nerve preparations). In separate nerve-modulation (EU-paired) experiments, single-pulse US (PD 0.05/0.1/1/10/100/500 ms) with maximum pressures of 1.62, 1.17 and 2.7 MPa and minimum pressures of 0.03, 0.05 and 0.16 MPa (for the 0.22, 0.52 and 1 MHz transducers respectively) was paired with electrical stimulation of the foot to assess suppression of sciatic-nerve compound action potentials.

Flags from extraction

  • exposures[*].timing.pulse_duration_msPulse-duration/duty-cycle/PRF/TD ranges are stated once in Methods as the general parameter space tested with each of the three transducers (per Fig. 2 caption); the paper does not confirm the full sweep was completed identically at all three frequencies, only that 'these parameters (B, C, and E) were tested across ten animals.'
  • exposures[*].free_field.pressure_kpaA second, distinct pressure range specific to the nerve-modulation (EU-paired) experiments is also given per transducer (max 1.62/1.17/2.7 MPa, min 0.03/0.05/0.16 MPa for 0.22/0.52/1 MHz) that differs from the broader excitation-testing range recorded here; both ranges are described in protocol_description.
  • exposures[*].free_field.isppa_w_cm2Aggregate maximum intensities are reported in the Discussion (ISPTA up to 62.48 W/cm2, ISPPA up to 833 W/cm2) but are not clearly attributed to a single specific transducer/frequency, so left not_reported per exposure rather than assigned to one frequency.
  • n_subjectsTotal of 41 guinea pigs used across the whole study; individual sub-experiments (e.g., 'five animals' for the parameter-response map, 'three animals' for thermal controls) used smaller, overlapping subsets not separately itemised here.